How Alnylam Pharmaceuticals, Inc.'s share price moved after each results release, and its latest quarters.
Alnylam Pharmaceuticals, Inc. has moved on average 15.12% (up or down) on the trading day after its last 4 results, and rose after 3 of its last 8. The biggest move was a fall of 28.3% on 30 Jul 2026. At today's price of $165.04, an average-sized move would be about $24.95 a share.
| Results filed | Opened | Closed |
|---|---|---|
| 29 Oct 2026 | -20.14% | -25.13% |
| 30 Jul 2026 | -21.49% | -28.31% |
| 30 Apr 2026 | +2.09% | +2.76% |
| 12 Feb 2026 | -2.44% | -4.28% |
| 12 Jan 2026 | -5.14% | -6.87% |
| 30 Oct 2025 | -6.56% | -6.65% |
| 31 Jul 2025 | +3.00% | +15.43% |
| 13 Jan 2025 | +0.85% | +8.53% |
Against the close before the release. A release before the 16:00 New York close counts that day; after the close, the next trading day.
| Quarter ended | Revenue | Profit | EPS |
|---|---|---|---|
| 30 Sept 2026 | $1.46 B | $2.17 B | $15.72 |
| 30 Jun 2026 | $1.29 B | $164 M | $1.21 |
| 31 Mar 2026 | – | $206 M | – |
| 31 Dec 2025 | $1.10 B | $112 M | $0.88 |
| 30 Sept 2025 | $1.25 B | $293 M | $2.14 |
| 30 Jun 2025 | $774 M | $-72 M | $-0.55 |
| 31 Mar 2025 | $594 M | $-18 M | $-0.14 |
| 31 Dec 2024 | $593 M | $-84 M | $-0.66 |
From the company's SEC filings (10-Q and 10-K).
Alnylam Pharmaceuticals, Inc. stock page › · Earnings calendar ›
Release times from SEC filings; next date and EPS estimate from Nasdaq's earnings calendar; prices from all US exchanges. Information only, not investment advice.
On average 15.12% (up or down) on the trading day after its last 4 results, from its SEC filing times and daily closes.
Not announced yet. Companies usually report about 3 to 6 weeks after each quarter ends.